DFFN
Price:
$4.4
Market Cap:
$8.98M
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.[Read more]
Industry
Biotechnology
IPO Date
2008-05-23
Stock Exchange
NASDAQ
Ticker
DFFN
According to Diffusion Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.62. This represents a change of -173.75% compared to the average of 0.84 of the last 4 quarters.
The mean historical PE Ratio of Diffusion Pharmaceuticals Inc. over the last ten years is -2.69. The current -0.62 PE Ratio has changed 2.20% with respect to the historical average. Over the past ten years (40 quarters), DFFN's PE Ratio was at its highest in in the December 2017 quarter at 2.31K. The PE Ratio was at its lowest in in the December 2019 quarter at -15438.76.
Average
-2.69
Median
-1.12
Minimum
-16.10
Maximum
-0.26
Discovering the peaks and valleys of Diffusion Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.73%
Maximum Annual PE Ratio = -0.26
Minimum Annual Increase = -96.73%
Minimum Annual PE Ratio = -16.10
Year | PE Ratio | Change |
---|---|---|
2022 | -1.02 | -17.47% |
2021 | -1.23 | -59.16% |
2020 | -3.02 | 1.05% |
2019 | -0.26 | -50.30% |
2018 | -0.53 | -96.73% |
2017 | -16.10 | 737.27% |
2016 | -1.92 | 174.30% |
2015 | -0.70 | 10.42% |
2014 | -0.63 | -57.77% |
2013 | -1.50 | 1.73% |
The current PE Ratio of Diffusion Pharmaceuticals Inc. (DFFN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.76
5-year avg
-1.21
10-year avg
-2.69
Diffusion Pharmaceuticals Inc.’s PE Ratio is less than Bio-Path Holdings, Inc. (-0.14), less than Catalyst Biosciences, Inc. (-0.44), greater than Capricor Therapeutics, Inc. (-4.65), greater than NextCure, Inc. (-0.65), less than Tonix Pharmaceuticals Holding Corp. (-0.00), less than Jaguar Health, Inc. (-0.07), greater than Acasti Pharma Inc. (-2.21), less than iBio, Inc. (-0.29), less than Pulmatrix, Inc. (0), greater than Akari Therapeutics, Plc (-0.67), greater than Soleno Therapeutics, Inc. (-1.55), greater than Cellectar Biosciences, Inc. (-28.67), greater than Monopar Therapeutics Inc. (-1.20), greater than Tenax Therapeutics, Inc. (-1.18), greater than null (-1.45),
Company | PE Ratio | Market cap |
---|---|---|
-0.14 | $2.51M | |
-0.44 | $19.42M | |
-4.65 | $132.76M | |
-0.65 | $39.73M | |
-0.00 | $3.14M | |
-0.07 | $10.26M | |
-2.21 | $24.44M | |
-0.29 | $15.35M | |
0 | $7.30M | |
-0.67 | $35.02M | |
-1.55 | $1.89B | |
-28.67 | $74.57M | |
-1.20 | $8.41M | |
-1.18 | $12.54M | |
-1.45 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Diffusion Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Diffusion Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Diffusion Pharmaceuticals Inc.'s PE Ratio?
How is the PE Ratio calculated for Diffusion Pharmaceuticals Inc. (DFFN)?
What is the highest PE Ratio for Diffusion Pharmaceuticals Inc. (DFFN)?
What is the 3-year average PE Ratio for Diffusion Pharmaceuticals Inc. (DFFN)?
What is the 5-year average PE Ratio for Diffusion Pharmaceuticals Inc. (DFFN)?
How does the current PE Ratio for Diffusion Pharmaceuticals Inc. (DFFN) compare to its historical average?